Endofotonics is a medtech company which uses its proprietary fiber-based Raman spectroscopy and AI platform to assist clinicians in detecting cancer early. By diagnosing cancer in its earlier stage, we aim to improve patient prognosis and lessen cancer burden. Founded in 2013, Endofotonics developed the SPECTRA IMDx™– the world's first real-time in-vivo Raman spectroscopy system. In early 2020, Endofotonics had successfully raised funding in Series B to fuel her expansion into the neighbouring Asian region.